Back to Search
MICHAEL VAGLICA, DDS, MD
DDS, MD
General Practice Dentistry
NPI: 1699415554Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DN27288(FL)22DI02933600(NJ)
Research & Publications (9)
Weekly docetaxel in the treatment of metastatic breast cancer.
PMID 19209285·Ther Clin Risk Manag·2008
8-other
Cytokine gene polymorphisms and breast cancer susceptibility.
PMID 17261759·Ann N Y Acad Sci·2006
8-other
Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
PMID 17261758·Ann N Y Acad Sci·2006
8-other
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
PMID 17109447·Cancer·2006
3-trial
High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL).
PMID 16966287·Leuk Lymphoma·2006
5-case
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
PMID 16020974·Oncology·2005
3-trial
Doxorubicin-docetaxel sequential schedule: results of front-line treatment in advanced breast cancer.
PMID 12381898·Oncology·2002
3-trial
Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
PMID 11810041·Oncology·2002
3-trial
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
PMID 11557121·Lung Cancer·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 451 CLARKSON AVE
BROOKLYN, NY 11203 - Phone
- (718) 245-2299
Quick Facts
- NPI
- 1699415554
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile